106 related articles for article (PubMed ID: 6548621)
1. Gastric cytoprotective properties of SCH 32651, a novel antiulcer agent.
Chiu PJ; Barnett A; Gerhart C; Policelli M; Kaminski J
Arch Int Pharmacodyn Ther; 1984 Jul; 270(1):128-40. PubMed ID: 6548621
[TBL] [Abstract][Full Text] [Related]
2. Protective action of SCH 12223 against experimentally induced gastric and intestinal lesions.
Chiu PJ; Barnett A; Siegel M; Brown AD; Gerhart C
J Pharmacol Exp Ther; 1988 Aug; 246(2):578-84. PubMed ID: 3404447
[TBL] [Abstract][Full Text] [Related]
3. Gastric antisecretory and cytoprotective activities of SCH 28080.
Long JF; Chiu PJ; Derelanko MJ; Steinberg M
J Pharmacol Exp Ther; 1983 Jul; 226(1):114-20. PubMed ID: 6864535
[TBL] [Abstract][Full Text] [Related]
4. Gastric antisecretory properties of SCH 32651.
Chiu PJ; Barnett A; Tetzloff G; Kaminski J
Arch Int Pharmacodyn Ther; 1984 Jul; 270(1):116-27. PubMed ID: 6238577
[TBL] [Abstract][Full Text] [Related]
5. Gastric and duodenal antiulcer and cytoprotective effects of proglumide in rats.
Tariq M; Parmar NS; Ageel AM
J Pharmacol Exp Ther; 1987 May; 241(2):602-7. PubMed ID: 3572816
[TBL] [Abstract][Full Text] [Related]
6. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
Nishida A; Takinami Y; Yuki H; Kobayashi A; Akuzawa S; Kamato T; Ito H; Yamano M; Nagakura Y; Miyata K
J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
[TBL] [Abstract][Full Text] [Related]
7. Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester.
Roszkowski AP; Garay GL; Baker S; Schuler M; Carter H
J Pharmacol Exp Ther; 1986 Nov; 239(2):382-9. PubMed ID: 3095537
[TBL] [Abstract][Full Text] [Related]
8. Antiulcer effects of 3-[[[2-(3,4-dimethoxyphenyl)ethyl] carbamoyl]methyl]-amino-N-methylbenzamide in experimental gastric and duodenal ulcers.
Asano M; Kurebayashi Y; Ryokawa Y; Hashizume T; Akashi A
Arzneimittelforschung; 1990 Mar; 40(3):276-81. PubMed ID: 2346535
[TBL] [Abstract][Full Text] [Related]
9. Effects of a gastric antisecretory-cytoprotectant 2-methyl-8-(phenylmethoxy)imidazo[1,2-a]pyridine-3-acetonitrile (Sch 28 080) on cysteamine, reserpine and stress ulcers in rats.
Chiu PJ; Gerhart C; Brown AD; Barnett A
Arzneimittelforschung; 1984; 34(7):783-6. PubMed ID: 6594140
[TBL] [Abstract][Full Text] [Related]
10. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
Sekiguchi H; Hamada K; Taga F; Nishino K
Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133
[TBL] [Abstract][Full Text] [Related]
11. Gastric antisecretory and antiulcer/cytoprotective effects of 2-cyano-3-(ethylthio-3-methylthio)-2-propenoic acid methyl ester.
Borella LE; DiJoseph JF
Arzneimittelforschung; 1989 May; 39(5):598-601. PubMed ID: 2547390
[TBL] [Abstract][Full Text] [Related]
12. Effects of the novel anti-ulcer agent 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine on experimental ulcers and gastric secretion in rats.
Tanaka T; Bickel M; Herling AW; Sakurai M; Goto M; Hayashi S
Arzneimittelforschung; 1989 Jun; 39(6):689-94. PubMed ID: 2775336
[TBL] [Abstract][Full Text] [Related]
13. Antiulcer activity of Utleria salicifolia rhizome extract.
Rao ChV; Ojha SK; Radhakrishnan K; Govindarajan R; Rastogi S; Mehrotra S; Pushpangadan P
J Ethnopharmacol; 2004 Apr; 91(2-3):243-9. PubMed ID: 15120446
[TBL] [Abstract][Full Text] [Related]
14. Effect of quinacrine, a phospholipase A2 inhibitor on stress and chemically induced gastroduodenal ulcers.
Al Moutaery AR; Tariq M
Digestion; 1997; 58(2):129-37. PubMed ID: 9144302
[TBL] [Abstract][Full Text] [Related]
15. Gastric antiulcer and cytoprotective effects of dipyridamole in rats.
Tariq M; Ageel AM
J Pharmacol Exp Ther; 1990 Jun; 253(3):944-9. PubMed ID: 2359030
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of UP 5145-52, an original antiulcer and antisecretory agent.
Dedieu-Chaufour C; Hertz F; Caussade F; Cloarec A
J Pharmacol Exp Ther; 1991 Oct; 259(1):190-7. PubMed ID: 1656018
[TBL] [Abstract][Full Text] [Related]
17. Gastric antisecretory and antiulcer effects of WHR1582A, a compound exerting alpha-2 adrenoceptor agonist activity.
DiJoseph JF; Eash JR; Mir GN
J Pharmacol Exp Ther; 1987 Apr; 241(1):97-102. PubMed ID: 2883297
[TBL] [Abstract][Full Text] [Related]
18. Cytoprotective and antiulcer activities of the antacid magaldrate in the rat.
Borella LE; DiJoseph JF; Mir GN
Arzneimittelforschung; 1989 Jul; 39(7):786-9. PubMed ID: 2783181
[TBL] [Abstract][Full Text] [Related]
19. Gastric cytoprotective, antisecretory and antiulcer activities of (E)-4-oxo-4-(3,4,5-trimethoxyphenyl)-2-butenoic acid (RU 38086).
Barzaghi F; Cesana R; Delevallée F; Fournex R; Nencioni A; Vincent JC; Deraedt R
Arzneimittelforschung; 1985; 35(9):1412-6. PubMed ID: 4084342
[TBL] [Abstract][Full Text] [Related]
20. Effects of cimetidine, a histamine H2-receptor antagonist, on various experimental gastric and duodenal ulcers.
Okabe S; Takeuchi K; Urushidani T; Takagi K
Am J Dig Dis; 1977 Aug; 22(8):677-84. PubMed ID: 18007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
